PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Longer-term follow-up of users of estrogen therapy finds some changes in risks

2011-04-06
(Press-News.org) Among postmenopausal women with prior hysterectomy who had used estrogen therapy for about 6 years and then stopped, longer-term follow-up indicates that the increased risk of stroke seen during the intervention period had dissipated, the decreased risk of hip fracture was not maintained, while the decreased risk of breast cancer persisted, according to a study in the April 6 issue of JAMA.

"The Women's Health Initiative (WHI) Estrogen-Alone Trial was a double-blind, placebo-controlled, randomized clinical trial evaluating the effects of conjugated equine estrogens (CEE) on chronic disease incidence among postmenopausal women with prior hysterectomy," the authors write. The trial intervention was stopped 1 year early after an average of 7.1 years of follow-up because of an increased risk of stroke and little likelihood of altering the balance of risk to benefit by the planned termination date. All previous reports of this trial were limited to health outcomes occurring during the intervention phase, according to background information in the article.

Andrea Z. LaCroix, Ph.D., of the Fred Hutchinson Cancer Research Center, Seattle, and colleagues analyzed data on health outcomes after the CEE intervention through an average of 10.7 years of follow-up, through August 2009. The intervention phase was a clinical trial of 0.625 mg/d of CEE compared with placebo in 10,739 U.S. postmenopausal women, ages 50 to 79 years with prior hysterectomy. Follow-up continued after the planned trial completion date among 7,645 surviving participants (78 percent) who provided written consent.

The researchers found that the risk for coronary heart disease (CHD) during the postintervention follow-up period was similar to that observed during the intervention. The increased stroke risk seen during the intervention phase was not present during the postintervention phase (0.36 percent [n = 66]) in the CEE group vs. 0.41 percent [n = 77] in the placebo group. Similarly, the increase in deep vein thrombosis and pulmonary embolism with CEE use compared with placebo during the intervention phase was not maintained during the postintervention phase.

The risk of invasive breast cancer in women randomized to CEE vs. placebo was similar during the intervention and postintervention phases. "Consequently, a statistically significant lower cumulative breast cancer incidence of 0.27 percent was seen in the CEE group (n = 151) compared with 0.35 percent in the placebo group (n=199). Colorectal cancer incidence did not differ between the women in the CEE group and the placebo group during the intervention or postintervention periods," the authors write.

They add that the reduced hip fracture risk seen during the intervention phase with CEE was not maintained in the postintervention phase, with hip fracture incidence slightly higher in the CEE group compared with the placebo group during the postintervention phase. Randomization to CEE did not influence total mortality during the intervention or postintervention phase. Health outcomes were more favorable for younger compared with older women for CHD, heart attack, colorectal cancer, total mortality, and a global index of chronic diseases .

"Our results emphasize the need to counsel women about hormone therapy differently depending on their age and hysterectomy status. A postmenopausal woman who has had a hysterectomy and is considering initiation of CEE should be counseled about the increased risks of venous thromboembolism and stroke during treatment, which diminish with treatment cessation. Among younger women, no new safety concerns emerged and some risk reductions became apparent during the postintervention period. Among older women, risks of colorectal cancer, death, and the global index of chronic diseases were elevated over the cumulative follow-up period. The risks and benefits of CEE use for periods of longer than 5 to 6 years cannot be inferred from these data for any age group. Mechanisms underlying the reduced risks of breast cancer in all women, and coronary events in younger but not older women, warrant further study," the authors conclude.

(JAMA. 2011;305[13]1305-1314. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Editorial: Short-term Use of Unopposed Estrogen - A Balance of Inferred Risks and Benefits

In an accompanying editorial, Emily S. Jungheim, M.D., M.S.C.I., and Graham A. Colditz, M.D., Dr.P.H., of the Washington University School of Medicine, St. Louis, write that findings from the WHI have been an important guide for clinicians on the overall risks and benefits of hormone therapy (HT).

"There may still be a role for short-term use of unopposed estrogen for treating some women with menopausal symptoms, but this role may be vanishing as existing and emerging data continue to be better understood in terms of application to patients. In the meantime, the symptoms of menopause can be significant and require thoughtful management. This would include careful consideration and discussion of the long-term risks and short-term benefits of HT as well as thorough discussion of other treatment strategies and optimization of lifestyle to ensure the best outcomes for women in the many years they should enjoy post-menopause."

(JAMA. 2011;305[13]1354-1355. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including financial disclosures, funding and support, etc.

To contact Andrea Z. LaCroix, Ph.D., call Kristen Woodward at 206-667-5095 or email kwoodwar@fhcrc.org. To contact editorial co-author Graham A. Colditz, M.D., Dr.P.H., call Judy Martin at 314-286-0105 or email martinju@wusm.wustl.edu.

### For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.


ELSE PRESS RELEASES FROM THIS DATE:

OC Fitness Boot Camp Teaches Women 'How to Look Horrible in your Wedding Dress in 10 Easy Steps!'

2011-04-06
The big day is rapidly approaching, and you're more than a little stressed about how you're going to look in that spectacular in that costly wedding dress. According top fitness trainer and OC Boot Camp Founder Rod Edmondson, there are 10 mistakes that women routinely make to unintentionally sabotage their fitness goals. 1. Start by starving yourself! Drastically reducing your caloric intake is tempting, but don't do it! It not only depletes essential vitamins and minerals from your body, but also slows your metabolism and prompts your body to cannibalize lean muscle ...

Blood biomarker associated with prevalence, severity of Alzheimer's, but not risk of development

2011-04-06
Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA. Clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with Alzheimer disease (AD), and have been suggested to be involved in the pathogenesis of AD. "Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression ...

Risk of death from opioid overdose related to higher prescription dose

2011-04-06
In an analysis of opioid prescription patterns and deaths, receiving higher prescribed doses is associated with an increased risk of opioid overdose death, but receiving both as-needed and regularly scheduled doses is not associated with overdose risk, according to a study in the April 6 issue of JAMA. The rate of overdose death has increased sharply in the United States in the past decade and overdose death is a pressing public health problem, according to background information in the article. "Between 1999 and 2007, the rate of unintentional overdose death in the United ...

The Latest Virtual Summit Press Release To Give Women Business Owners Less Stress And More Success.

2011-04-06
Six expert business coaches and consultants are launching a "virtual summit" designed to fit the busy schedules of women business owners. The Make it Happen! Virtual Summit kicks off April 19 and focuses on presenting information that can be implemented quickly into action steps leading to high-impact results. The Make it Happen Virtual Summit is geared to women who are ready to strategically prioritize their business and life goals to enhance professional success and personal fulfillment with less stress. Topics include developing a powerful profit-boosting marketing ...

HIV-1 drug resistance mutations associated with increased risk of antiretroviral treatment failure

2011-04-06
An analysis of data from 10 studies indicates that the presence of low frequency (also called "minority") human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance, are significantly associated with an increased risk of first-line antiretroviral treatment failure, according to an article in the April 6 issue of JAMA. Using traditional tests, the prevalence of transmitted drug resistance mutations is estimated to be between 8 percent and 16 percent among HIV-1 infected ...

Death rates after hospitalization down for oldest heart failure patients

2011-04-06
Death rates after hospitalization for heart failure have dropped for veterans age 80 and older, but rehospitalizations remain frequent, according to a study in the American Heart Association journal Circulation: Heart Failure. Results of the study highlight a need to better identify which patients among the oldest are more likely to be rehospitalized not just for heart failure, but for any reason, said Rashmee Shah, M.D., lead author of the study and postdoctoral fellow in the Department of Health Research and Policy at Stanford University School of Medicine in Palo Alto, ...

AIT Becomes the First Software Vendor in American Translators Association's Member-Provider Program

2011-04-06
Advanced International Translations (AIT), a leading supplier of translation management software for agencies and freelancers, became the first member-provider software company in the American Translators Association (ATA). ATA's Member-Provider Program was established to provide support to members in their practice of translation and interpreting. Vendors in the program are selected after careful review of the company's products, services, reliability, and value. The selection process includes feedback and recommendations from ATA members about the vendor and its products. Participation ...

Off-label marketing of medicines in the US is rife but difficult to control

2011-04-06
Despite Federal Drug Administration regulation of the approval and use of pharmaceutical products, "off-label" marketing of drugs (for purposes other than those for which the drug was approved) has occurred in all aspects of the US health care system. In a study published in this week's PLoS Medicine, Aaron S. Kesselheim from Brigham and Women's Hospital, Boston, USA and colleagues report that the most common alleged off-label marketing practices also appear to be the most difficult to control through external regulatory approaches. They identified three main goals of alleged ...

Comprehensive approach can improve clinical care of Kenyan children

2011-04-06
A multifaceted approach that addressed deficiencies in clinical knowledge, skills, motivation, resources, and the organization of care was associated with improvements in practice for high mortality conditions in young children in rural Kenya compared with less comprehensive approaches. This finding from a novel study by Philip Ayieko from the KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya, and colleagues, published in this week's PLoS Medicine, is important as it suggests that specific efforts are needed to improve pediatric care in rural areas of poor countries ...

Effects of pneumococcal vaccination program on pneumococcal carriage and invasive disease

2011-04-06
Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease. There are more than 90 Streptococcus pneumoniae serotypes that can cause invasive pneumococcal disease (IPD). The pneumococcal conjugate vaccine PCV7 contains antigens from seven serotypes responsible for IPD. Immunization with PCV7 prevents both IPD disease and carriage of these seven serotypes, but after vaccination non-vaccine serotypes could colonize the nasopharynx. There ...

LAST 30 PRESS RELEASES:

High-quality nanodiamonds for bioimaging and quantum sensing applications

New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia

Evolution of fast-growing fish-eating herring in the Baltic Sea

Cryptographic protocol enables secure data sharing in the floating wind energy sector

Can drinking coffee or tea help prevent head and neck cancer?

Development of a global innovative drug in eye drop form for treating dry age-related macular degeneration

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

[Press-News.org] Longer-term follow-up of users of estrogen therapy finds some changes in risks